GlassScriptPhysician profile
Trevor Michael Gerber
NPI 1083632335
$1,879.12
in general payments reported to CMS, 2019-2025
19 companies · $360 in 2025
The $360 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $447 · 2022: $324 · 2023: $105 · 2024: $643 · 2025: $360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,108.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $416.31 | 2021-2022 | |
| Kls-Martin L.P. | $220.37 | 2023-2025 | |
| Corcym INC | $198.63 | 2024 | Perceval |
| Atricure, INC. | $179.47 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Abbott Laboratories | $135.79 | 2024-2025 | Epic, Amplatzer Amulet, Perclose Prostyle |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $134.33 | 2022-2024 | Lifevest |
| Boston Scientific Corporation | $96.40 | 2022-2025 | General - Therapies, Watchman Flx |
| W. L. Gore & Associates, INC. | $91.28 | 2022-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Tactile Systems Technology INC | $79.82 | 2021 | |
| Amgen INC. | $63.92 | 2023-2024 | Repatha |
| Ethicon US, LLC | $44.83 | 2021 | |
| Novartis Pharmaceuticals Corporation | $40.37 | 2022-2024 | |
| Abiomed | $40.27 | 2025 | |
| Koya Medical, INC. | $31.00 | 2025 | Dayspring, Koya Medical |
| Merck Sharp & Dohme LLC | $23.74 | 2024 | Verquvo |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $23.36 | 2025 | |
| Chiesi USA, INC. | $22.56 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.79 | 2023 | Camzyos |
| Astrazeneca Pharmaceuticals LP | $15.88 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trevor Gerber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.